355 related articles for article (PubMed ID: 3802423)
1. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
Toth PD; Mikulaschek AW
Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
3. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
Natsume Y; Imanishi N; Koike H; Morooka S
Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
[TBL] [Abstract][Full Text] [Related]
4. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
Qi M; Jones SB
Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of SR 27417, a novel PAF antagonist, on PAF- or endotoxin-induced hypotension in the rat and the guinea-pig.
Bernat A; Herbert JM; Salel V; Lespy L; Maffrand JP
J Lipid Mediat; 1992 Feb; 5(1):41-8. PubMed ID: 1391738
[TBL] [Abstract][Full Text] [Related]
6. Is platelet activating factor (PAF) a mediator of endotoxin shock?
Terashita Z; Imura Y; Nishikawa K; Sumida S
Eur J Pharmacol; 1985 Feb; 109(2):257-61. PubMed ID: 3996473
[TBL] [Abstract][Full Text] [Related]
7. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxin-induced changes in rat mesenteric microcirculation.
Li SH; Fei X; Gong XQ; Wu ZL
Yao Xue Xue Bao; 1991; 26(1):6-9. PubMed ID: 1887797
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ
Circ Shock; 1987; 23(3):179-88. PubMed ID: 3427772
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
[TBL] [Abstract][Full Text] [Related]
10. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B
Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134
[TBL] [Abstract][Full Text] [Related]
11. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
[TBL] [Abstract][Full Text] [Related]
12. [Involvement of platelet activating factors in pathologic leukocyte-endothelium interactions in the liver after hemorrhagic shock].
Marzi I; Bauer M; Reisdorf E; Walcher F
Zentralbl Chir; 1994; 119(11):814-21. PubMed ID: 7846961
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
14. Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
Sun XM; Hsueh W; Torre-Amione G
Am J Pathol; 1990 Apr; 136(4):949-56. PubMed ID: 2327475
[TBL] [Abstract][Full Text] [Related]
15. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
[TBL] [Abstract][Full Text] [Related]
16. The role of platelet-activating factor in conscious, normotensive endotoxemia.
Ephgrave K; Kremer T; Broadhurst K; Cullen J
J Surg Res; 1997 Mar; 68(2):170-4. PubMed ID: 9184676
[TBL] [Abstract][Full Text] [Related]
17. Role of adrenal steroids in the recovery from platelet activating factor challenge.
Myers AK; Bader TJ
Circ Shock; 1987; 23(2):143-50. PubMed ID: 3677334
[TBL] [Abstract][Full Text] [Related]
18. Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone.
Feuerstein G; Lux WE; Snyder F; Ezra D; Faden AI
Circ Shock; 1984; 13(3):255-60. PubMed ID: 6432359
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor antagonists in experimental shock.
Muacevic G; Heuer HO
Arzneimittelforschung; 1992 Aug; 42(8):1001-4. PubMed ID: 1418068
[TBL] [Abstract][Full Text] [Related]
20. The effects of vasoactive mediator antagonists on endotoxic shock in dogs. I.
Toth PD; Hamburger SA; Judy WV
Circ Shock; 1984; 12(4):277-86. PubMed ID: 6722995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
